South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
Ipinnia XL or Repinex XL are the preferred cost-effective MR brands (Applicable in primary care).
04.09.01
Levodopa
04.09.01
Monoamine-oxidase-B inhibitors
04.09.01
Catachol-O-methyltransferase inhibitors
....
Non Formulary Items
Bromocriptine
Non Formulary
Cabergoline (Cabaser®)
Non Formulary
Lisuride
Non Formulary
Pergolide (Celance®)
Non Formulary
non formulary- NICE states rarely used now due to fibrotic reactions for which there has been a MHRA safety warning
Rotigotine
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)
Suitable first-line drugs for implementation in Primary Care